Why the ISLET Act Matters Right Now for the Type 1 Diabetes Community
For decades, researchers have known that transplanting pancreatic islet cells — the insulin-producing cells destroyed in type one diabetes (T1D) — has the potential to dramatically improve lives. Yet, in the United States, access to islet transplantation has been slowed by a regulatory barrier: Human cadaveric islets are classified as...
